Synfacts, Table of Contents Synfacts 2023; 19(03): 0304DOI: 10.1055/s-0042-1752401 Innovative Drug Discovery and Development Small Molecule SST2 Agonist as a Potential Therapeutic for Acromegaly and Neuroendocrine Tumors Authors Contributor(s): Antonia F. Stepan (Roche) Nadine Kuhl (MSD) Danica A. Rankic (Pfizer) Recommend Article Abstract Buy Article(opens in new window)Key words Key wordssomatostatin - paltusotine - SST2 agonist - acromegaly - neuroendocrine tumors - Suzuki coupling Full Text